Items where authors include "Chiò, A."

Article

Costello, E. orcid.org/0000-0001-8620-9531, De Vocht, J., Beswick, E. et al. (29 more authors) (2025) Neuropsychological assessment practices in PRECISION-ALS: challenges and opportunities for harmonization. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. ISSN 2167-8421

Lovett, A., Chary, S., Babu, S. et al. (15 more authors) (2025) Serious neurologic adverse events in Tofersen clinical trials for amyotrophic lateral sclerosis. Muscle & Nerve, 71 (6). pp. 1006-1015. ISSN 0148-639X

McFarlane, R. orcid.org/0000-0001-7380-4219, Opie-Martin, S., Caravaca Puchades, A. et al. (26 more authors) (2025) Clinical trajectories of genetic variants in ALS: a European observational study within PRECISION-ALS. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 26 (sup 1). pp. 41-49. ISSN 2167-8421

McDonough, H., McFarlane, R. orcid.org/0000-0001-7380-4219, Caravaca Puchades, A. et al. (26 more authors) (2025) Examining changing working status and caregiver assistance in amyotrophic lateral sclerosis (ALS) using large-scale European databases as part of PRECISION-ALS. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 26 (sup 1). pp. 20-29. ISSN 2167-8421

Caravaca Puchades, A., McDonough, H.E., Al-Chalabi, A. et al. (26 more authors) (2025) Mapping the natural history of amyotrophic lateral sclerosis: time-to-event analysis of clinical milestones in the pan-European, population-based PRECISION-ALS cohort. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 26 (sup1). pp. 8-19. ISSN 2167-8421

van Eijk, R.P.A. orcid.org/0000-0002-7132-5967, Weemering, D.N. orcid.org/0009-0005-4182-3294, Opie-Martin, S. et al. (27 more authors) (2025) Natural history of the revised ALS functional rating scale and its association with survival: the PRECISION-ALS Extant Study. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 26 (sup 1). pp. 30-40. ISSN 2167-8421

Vasta, R., Ombelet, F., Hobin, F. et al. (26 more authors) (2025) Real-world prognostic role of riluzole use in ALS: a multi-center study from PRECISION-ALS. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 26 (sup1). pp. 50-60. ISSN 2167-8421

Sennfält, S., Al-Chalabi, A., Caravaca Puchades, A. et al. (26 more authors) (2025) Respiratory function, survival, and NIV prevalence over time in ALS - a PRECISION ALS study. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 26 (sup1). pp. 61-72. ISSN 2167-8421

Saez-Atienzar, S., Souza, C.D.S., Chia, R. et al. (323 more authors) (2024) Mechanism-free repurposing of drugs for C9orf72-related ALS/FTD using large-scale genomic data. Cell Genomics, 4 (11). 100679. ISSN 2666-979X

Taş, G. orcid.org/0009-0008-2409-0246, Westerdijk, T., Postma, E. et al. (87 more authors) (2024) Computing linkage disequilibrium aware genome embeddings using autoencoders. Bioinformatics, 40 (6). btae326. ISSN 1367-4803

Van Damme, P. orcid.org/0000-0002-4010-2357, Al‐Chalabi, A. orcid.org/0000-0002-4924-7712, Andersen, P.M. et al. (17 more authors) (2024) European Academy of Neurology (EAN) guideline on the management of amyotrophic lateral sclerosis in collaboration with European Reference Network for Neuromuscular Diseases (ERN EURO-NMD). European Journal of Neurology, 31 (6). e16264. ISSN 1351-5101

Lombardo, F.L. orcid.org/0000-0001-6183-0735, Spila Alegiani, S., Mayer, F. et al. (93 more authors) (2023) A randomized double-blind clinical trial on safety and efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment in patients affected by amyotrophic lateral sclerosis (ALS): the statistical analysis plan of TUDCA-ALS trial. Trials, 24 (1). 792. ISSN 1468-6708

McFarlane, R., Galvin, M., Heverin, M. et al. (19 more authors) (2023) PRECISION ALS—an integrated pan European patient data platform for ALS. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 24 (5-6). pp. 389-393. ISSN 2167-8421

Chen, Z., Reynolds, R.H., Pardiñas, A.F. et al. (23 more authors) (2023) The contribution of Neanderthal introgression and natural selection to neurodegenerative diseases. Neurobiology of Disease, 180. 106082. ISSN 0969-9961

Miller, T.M., Cudkowicz, M.E., Genge, A. et al. (23 more authors) (2022) Trial of antisense oligonucleotide tofersen for SOD1 ALS. New England Journal of Medicine, 387 (12). pp. 1099-1110. ISSN 0028-4793

Hop, P.J. orcid.org/0000-0002-9007-7436, Zwamborn, R.A.J. orcid.org/0000-0003-3952-5042, Hannon, E. orcid.org/0000-0001-6840-072X et al. (151 more authors) (2022) Genome-wide study of DNA methylation shows alterations in metabolic, inflammatory, and cholesterol pathways in ALS. Science Translational Medicine, 14 (633). eabj0264. ISSN 1946-6234

Dewan, R. orcid.org/0000-0002-7611-7032, Chia, R. orcid.org/0000-0002-4709-7423, Ding, J. et al. (469 more authors) (2021) Pathogenic huntingtin repeat expansions in patients with frontotemporal dementia and amyotrophic lateral sclerosis. Neuron, 109 (3). 448-460.e4. ISSN 0896-6273

Rooney, J., Fogh, I., Westeneng, H.J. et al. (17 more authors) (2016) C9orf72 expansion differentially affects males with spinal onset amyotrophic lateral sclerosis. Journal of Neurology, Neurosurgery and Psychiatry. ISSN 0022-3050